PMC:7463108 / 89647-89848
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T37556 | 19-27 | Chemical | denotes | naloxone | http://purl.obolibrary.org/obo/CHEBI_7459 |
| T353 | 111-119 | Chemical | denotes | morphine | http://purl.obolibrary.org/obo/CHEBI_17303|http://purl.obolibrary.org/obo/CHEBI_58097 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3123 | 136-139 | Gene | denotes | MOR | Gene:4988 |
| 3164 | 43-46 | Gene | denotes | Tat | Gene:6898 |
| 3177 | 19-27 | Chemical | denotes | naloxone | MESH:D009270 |
| 3178 | 111-119 | Chemical | denotes | morphine | MESH:D009020 |
| 3191 | 47-55 | Disease | denotes | toxicity | MESH:D064420 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1172 | 0-201 | Sentence | denotes | Pre-treatment with naloxone re-established Tat toxicity, suggesting that the paradoxical protective effects of morphine are mediated by MOR (or perhaps another opioid receptor type) (d) (see Kim et al. |